Physician profile
Russel Hirsch
NPI 1285791160
$21,682.33
in general payments reported to CMS, 2019-2025
16 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $247 · 2021: $364 · 2022: $2,395 · 2023: $1,545 · 2024: $545 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119 · Travel and Lodging: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.55 |
| Travel and Lodging | $1,089.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $10,158.21 | 2019-2021 | |
| Abbott Laboratories | $6,341.55 | 2019-2021 | |
| Canon Medical Systems USA, INC. | $1,563.58 | 2022-2024 | Interventional Angiography System |
| Merck Sharp & Dohme LLC | $1,443.65 | 2022-2023 | |
| Siemens Medical Solutions USA, INC. | $1,003.62 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $310.25 | 2019-2024 | Uptravi, Opsumit |
| Medtronic Vascular, INC. | $247.11 | 2020 | |
| W. L. Gore & Associates, INC. | $189.46 | 2019-2025 | Gore Cardioform Septal Occluder |
| Medtronic, INC. | $174.06 | 2021-2024 | Harmony |
| Terumo Medical Corporation | $124.13 | 2019 | |
| United Therapeutics Corporation | $68.91 | 2023-2025 | Remodulin, Tyvaso, Remodulin |
| Bayer Healthcare Pharmaceuticals INC. | $22.78 | 2025 | |
| Cardiva Medical, INC. | $20.63 | 2025 | Cardiva Vascade 6/7f Vcs |
| Edwards Lifesciences Corporation | $14.39 | 2024 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russel Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.